Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucinex for Filamentary Keratitis
NCT02859246Completed
- Sponsor
- Massachusetts Eye and Ear
- Start
- Sep 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of acetaminophen in filamentary keratitis (FK), sponsored by Massachusetts Eye and Ear. Primary endpoint: Change in Number of Corneal Filaments at 4 weeks. Started Sep 2016; status: completed.
02
Drugs
acetaminophen
03
Conditions
filamentary keratitis (FK)
Beyond the preview
Go deeper on NCT02859246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02859246.